Randomized Phase II Trial of Neoadjuvant Docetaxel Plus Cisplatin and 5-Fluorouracil Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Cisplatin; Docetaxel; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 09 Jul 2008 Final results reported at ASCO 2008 (1113304).
- 14 Dec 2006 Status change
- 14 Sep 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History